[HTML][HTML] Novel biomarkers of atherosclerotic vascular disease—Latest insights in the research field

CA Adam, DL Șalaru, C Prisacariu, DTM Marcu… - International journal of …, 2022 - mdpi.com
The atherosclerotic vascular disease is a cardiovascular continuum in which the main role is
attributed to atherosclerosis, from its appearance to its associated complications. The …

Clinical utility of biomarkers in premature atherosclerosis

AM Kampoli, D Tousoulis… - Current medicinal …, 2012 - ingentaconnect.com
Atherosclerosis is a very complex procedure responsible for the development of coronary
artery disease which is the leading cause of death in the civilized world. The obvious …

[HTML][HTML] Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability

G Nieddu, M Formato, AJ Lepedda - International Journal of Molecular …, 2023 - mdpi.com
Plaque rupture and thrombosis are the most important clinical complications in the
pathogenesis of stroke, coronary arteries, and peripheral vascular diseases. The …

Quest for novel cardiovascular biomarkers by proteomic analysis

F Vivanco, JL Martín-Ventura, MC Duran… - Journal of proteome …, 2005 - ACS Publications
Atherosclerosis, and the resulting coronary heart disease and stroke, is the most common
cause of death in developed countries. Atherosclerosis is an inflammatory process that …

Biology of atherosclerotic plaques: what we are learning from proteomic analysis

LM Blanco-Colio, JL Martín-Ventura… - Cardiovascular …, 2006 - academic.oup.com
Atherosclerotic plaque rupture triggers the onset of cardiovascular complications such as
myocardial infarction and stroke, which represent the main cause of death in western …

The discovery of novel genomic, transcriptomic, and proteomic biomarkers in cardiovascular and peripheral vascular disease: the state of the art

S De Franciscis, L Metzinger… - BioMed research …, 2016 - Wiley Online Library
Cardiovascular disease (CD) and peripheral vascular disease (PVD) are leading causes of
mortality and morbidity in western countries and also responsible of a huge burden in terms …

[HTML][HTML] Atherosclerosis and its related laboratory biomarkers

V Della Corte, F Todaro, M Cataldi… - International Journal of …, 2023 - mdpi.com
Atherosclerosis constitutes a persistent inflammatory ailment, serving as the predominant
underlying condition for coronary artery disease (CAD), peripheral artery disease (PAD) …

[HTML][HTML] Vulnerable atherosclerotic plaque: is there a molecular signature?

RM Chiorescu, M Mocan, AI Inceu, AP Buda… - International Journal of …, 2022 - mdpi.com
Atherosclerosis and its clinical manifestations, coronary and cerebral artery diseases, are
the most common cause of death worldwide. The main pathophysiological mechanism for …

[HTML][HTML] Recognized and potentially new biomarkers—their role in diagnosis and prognosis of cardiovascular disease

W Bargieł, K Cierpiszewska, K Maruszczak, A Pakuła… - Medicina, 2021 - mdpi.com
Atherosclerosis and its consequences are the leading cause of mortality in the world. For
this reason, we have reviewed atherosclerosis biomarkers and selected the most promising …

Novel systemic cardiovascular disease biomarkers

GA Bonaterra, S Zugel… - Current molecular …, 2010 - ingentaconnect.com
Motivated by the challenge of risk assessment in a heterogeneous population and guided by
advances in our knowledge of the pathobiology of cardiovascular diseases (CVD), basic …